In phase II trials focusing on dermal applications, TB-500 has displayed promising outcomes for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa
He is a graduate of the University of Southern California School (USC) of Pharmacy and is now an Adjunct Assistant Professor of Pharmacy Practice at USC
Additional CD4 + subsets such as T follicular helper (Tfh) cells enhance B cell activation and autoantibody production, with higher Tfh counts linked to more severe disease (Cai et al., 2022)
[PubMed] [Google Scholar] Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono, K and Ichijo H